The Stony Brook University Calm-Mom Study
An Internet-Delivered Mind-Body Program for Reducing Prenatal Maternal Stress
2 other identifiers
interventional
79
1 country
1
Brief Summary
The present trial will evaluate the feasibility, acceptability and preliminary efficacy of 2 different internet-delivered programs for prenatal maternal stress. The Stress Managment and Resiliency Training Program (SMART-Mom program), an 8-session Cognitive Behavior Therapy (CBT) based mind body program and the Mama Support Program, an 8-session social support group program. Sixty pregnant women (\<20 weeks Estimated Gestational Age) will be screened and either enrolled in the online SMART Mom Program or the Mama Support Program. Outcomes, including maternal perceived stress, depression, and anxiety will be assessed at post-treatment, three, and six months post program completion. Potential impact on infant health outcomes will be assessed via post-delivery electronic medical record review.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2019
CompletedFirst Posted
Study publicly available on registry
July 12, 2019
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedAugust 1, 2023
July 1, 2023
2.2 years
July 9, 2019
July 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in perceived stress as indexed by Perceived Stress Scale (PSS) score
Gold standard measure of subjective stress experiences. Total scores range from 0 to 40; higher scores indicate greater stress.
baseline, 8 weeks post enrollment, 20 weeks post enrollment
Change in prenatal maternal distress as indexed by Prenatal Distress Questionnaire (NuPDQ) score
Measure of prenatal maternal distress. Total scores range form 0-35; higher scores indicate greater pregnancy-related distress.
baseline, 8 weeks post enrollment
Secondary Outcomes (4)
Patient-Reported Outcomes Measurement Information System (PROMIS) V.1 Emotional Distress-Depression
baseline, 8 weeks post enrollment, 20 weeks post enrollment
Patient-Reported Outcomes Measurement Information System (PROMIS) V.1 Emotional Distress-Anxiety
baseline, 8 weeks post enrollment, 20 weeks post enrollment
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
baseline, 8 weeks post enrollment, 20 weeks post enrollment
Measure of Current Status-Form A (MOCS-A)
baseline, 8 weeks post enrollment, 20 weeks post enrollment
Other Outcomes (2)
Birthweight
Chart review occurring at 6 week postpartum visit.
Gestational Age
Chart review occurring at 6 week postpartum visit.
Study Arms (2)
Intervention
EXPERIMENTALParticipants (n = 30) will be randomized to receive the SMART Pregnancy stress management program via an online portal.
Treatment as usual
ACTIVE COMPARATORParticipants (n = 30) will be randomized to receive treatment as usual, including referrals to community based support groups and individual mental health providers.
Interventions
SMART Pregnancy is an 8-session online stress management program offered in a group format. SMART Pregnancy is an adaptation of the Stress Management and Resiliency Training Program (Park et al., 2012).
Participants will be enrolled in an 8-week time and attention matched, process-based support group.
Eligibility Criteria
You may qualify if:
- \<21 weeks pregnant with medically confirmed viability
- Speak, read and write in English fluently,
- Endorse elevated levels of prenatal maternal stress (PNMS; i.e., New Prenatal Distress Questionnaire Score \> 19).
You may not qualify if:
- Current enrollment in individual or group psychotherapy
- Current un-managed serious mental illness including bipolar disorder and psychosis
- History of previous suicide attempt
- Inappropriate for participation in group therapy format as determined by study director
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stony Brook University, Department of Psychiatry
Stony Brook, New York, 11794, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brittain L Mahaffey, PhD
Stony Brook University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 9, 2019
First Posted
July 12, 2019
Study Start
April 1, 2021
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
August 1, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Timelines for distribution of data will vary, however the study team will make every effort to make data available in a timely fashion. It is expected that data from this proposal will presented at scientific meetings, and publications will be made available through PubMed Central no later than 12 months after publication.
- Access Criteria
- The data will be available to users under a data sharing agreement that includes a commitment to: 1) using the data for research purposes only, 2) properly securing the data in accordance with HIPAA compliance requirements, and 3) destroying the data after analyses are completed.
The investigators are committed to sharing the research data that is generated in this proposal. Research data will be shared according to NIH guidelines. All research data is collected and stored in accordance with HIPAA compliance, and any shared datasets resulting from human participant research will be free of any identifiers that would allow disclosure of individual subjects.